186 related articles for article (PubMed ID: 9255778)
1. Dusting off recombinant allergens.
Marshall GD; Davis F
Nat Biotechnol; 1997 Aug; 15(8):718-9. PubMed ID: 9255778
[No Abstract] [Full Text] [Related]
2. [Apropos of sublingual specific immunotherapy].
Sabbah A
Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
[No Abstract] [Full Text] [Related]
3. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.
Takai T; Yokota T; Yasue M; Nishiyama C; Yuuki T; Mori A; Okudaira H; Okumura Y
Nat Biotechnol; 1997 Aug; 15(8):754-8. PubMed ID: 9255789
[TBL] [Abstract][Full Text] [Related]
4. Humoral response in asthma patients sensitive to house dust mites during specific immunotherapy with Alutard SQ.
Chyrek-Borowska S; Szymański W; Złotnik I; Rogalewska A
Pneumonol Alergol Pol; 1992; 60 Suppl 1():49-52. PubMed ID: 1292846
[No Abstract] [Full Text] [Related]
5. The best allergen immunotherapy choice for mite allergic patients.
Ciprandi G; Incorvaia C; Masieri S; Buttafava S; Frati F
Expert Rev Clin Immunol; 2016 Jun; 12(6):603-4. PubMed ID: 26950287
[No Abstract] [Full Text] [Related]
6. Recombinant mite allergens. New technologies for the management of patients with asthma.
Chapman MD; Smith AM; Vailes LD; Arruda LK
Allergy; 1997 Apr; 52(4):374-9. PubMed ID: 9188916
[TBL] [Abstract][Full Text] [Related]
7. Mite allergens.
Caraballo L
Expert Rev Clin Immunol; 2017 Apr; 13(4):297-299. PubMed ID: 28162009
[No Abstract] [Full Text] [Related]
8. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
[TBL] [Abstract][Full Text] [Related]
9. [Do nasal and conjunctival provocation tests represent a trustworthy parameter for the follow-up of childhood IgE-dependent bronchial asthma?].
Botey J; Eseverri JL; Marin AM
Allerg Immunol (Paris); 1996 Feb; 28(2):52-4. PubMed ID: 8703310
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of major and minor Dermatophagoides allergens in canine atopic dermatitis.
Nuttall TJ; Lamb JR; Hill PB
Res Vet Sci; 2001 Aug; 71(1):51-7. PubMed ID: 11666148
[TBL] [Abstract][Full Text] [Related]
12. House dust sensitivity and asthma.
Whyte KF; Flenley DC
Q J Med; 1986 Feb; 58(226):89-93. PubMed ID: 3520627
[No Abstract] [Full Text] [Related]
13. Recombinant allergens for immunotherapy: a Der p 2 variant with reduced IgE reactivity retains T-cell epitopes.
Smith AM; Chapman MD; Taketomi EA; Platts-Mills TA; Sung SS
J Allergy Clin Immunol; 1998 Mar; 101(3):423-5. PubMed ID: 9525463
[No Abstract] [Full Text] [Related]
14. Molecular cloning and immunological characterization of the group 7 allergens of house dust mites.
Shen HD; Chua KY; Hsieh KH; Thomas WR
Adv Exp Med Biol; 1996; 409():241-2. PubMed ID: 9095248
[No Abstract] [Full Text] [Related]
15. Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy.
Oda N; Yamashita N; Minoguchi K; Takeno M; Kaneko S; Sakane T; Adachi M
Cell Immunol; 1998 Nov; 190(1):43-50. PubMed ID: 9826445
[TBL] [Abstract][Full Text] [Related]
16. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
[TBL] [Abstract][Full Text] [Related]
17. Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions.
Weghofer M; Thomas WR; Pittner G; Horak F; Valenta R; Vrtala S
Clin Exp Allergy; 2005 Oct; 35(10):1384-91. PubMed ID: 16238800
[TBL] [Abstract][Full Text] [Related]
18. Allergen-antibody complexes in the treatment of Dermatophagoides pteronyssinus hypersensitivity diseases.
Saint-Remy JM; Machiels JJ
Clin Exp Allergy; 1994 Dec; 24(12):1091-3. PubMed ID: 7889421
[No Abstract] [Full Text] [Related]
19. The current state of recombinant allergens for immunotherapy.
Pauli G; Malling HJ
Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
[TBL] [Abstract][Full Text] [Related]
20. Skin test and crossreactivity studies with Euroglyphus maynei and Dermatophagoides pteronyssinus.
Kemp SF; Lockey RF; Fernández-Caldas E; Arlian LG
Clin Exp Allergy; 1997 Aug; 27(8):893-7. PubMed ID: 9291285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
